Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Benitec Biopharma Ltd. ADR (BTEBY)

Add BTEBY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Wildbilly, Blane
Search This Board:
Last Post: 10/24/2014 8:26:15 PM - Followers: 38 - Board type: Free - Posts Today: 0
Silencing Genes For Life™

ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.

Our in-house pipeline is summarized below,  In-house pipeline


. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.





Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#1187  Sticky Note GREAT NEWS from BENITEC georgejjl 10/08/14 12:15:09 AM
#1024  Sticky Note Benitec Info/Due Diligence Consolidated 8-16-2014 Blane 08/16/14 03:16:25 PM
#1221   Sorry George, couldn't help myself. 2016 is a RCH68 10/24/14 08:26:15 PM
#1220   Be serious!!! georgejjl 10/24/14 05:22:14 PM
#1219   A good guess at this point would be RCH68 10/24/14 03:26:25 PM
#1218   dubbya According to information from georgejjl 10/24/14 02:55:23 PM
#1217   Has a time frame been given on when dubbya 10/24/14 12:16:48 PM
#1216   New Benitec Investor Relations APP georgejjl 10/23/14 10:29:55 PM
#1215   Benitec Interview October 24,2014 georgejjl 10/23/14 10:23:39 PM
#1214   News on Regulus 'Gene Silencing' today. Wildbilly 10/22/14 06:13:05 PM
#1213   Regarding TT-034 georgejjl 10/21/14 11:23:15 PM
#1212   Benitec annual report Blane 10/15/14 12:16:27 PM
#1211   Great, no info on this for a month. RCH68 10/15/14 06:53:06 AM
#1209   Yes I have the app but can't send PM's. RCH68 10/14/14 05:44:55 PM
#1208   I don't have private message ability, but I'll Blane 10/14/14 12:14:35 PM
#1207   That part was a little confusing. Here Blane 10/14/14 12:06:24 PM
#1206   I wish there was someway we could do RCH68 10/14/14 06:36:33 AM
#1205   The results of the mice tests were promising, RCH68 10/14/14 06:28:20 AM
#1204   What about the story made you change your Blane 10/13/14 11:35:39 PM
#1203   Nice. I might pull 1400 out of Blane 10/13/14 11:31:51 PM
#1202   If this stock gets back to the $5.50 RCH68 10/13/14 04:29:40 PM
#1201   Wow I sold today at 2.90 and almost SmokeyNYY 10/13/14 04:05:28 PM
#1200   Yeah, this really sucks, but our biggest play Blane 10/13/14 11:03:57 AM
#1199   Here is what we know that could RCH68 10/13/14 07:36:37 AM
#1198   Wow. What a piece of crap. Feels like SmokeyNYY 10/13/14 01:30:32 AM
#1197   NSCLC in the article didn't sound all that RCH68 10/10/14 07:47:59 AM
#1196   You heard it here first georgejjl 10/09/14 11:43:57 PM
#1195   Regen BioPharma Inc. Files IND Application With FDA bellweather1 10/09/14 02:54:39 PM
#1194   That's ok. We will take some more cheap Blane 10/08/14 04:33:23 PM
#1193   Yes, the market wants some freaking efficacy.. Unfortunately RCH68 10/08/14 04:27:22 PM
#1192   Sweet smokey...sitting at a little more than 6500 Blane 10/08/14 04:20:53 PM
#1191   Too bad we haven't moved much on that Blane 10/08/14 04:16:50 PM
#1190   Ok just bought some more at 3.76. That's SmokeyNYY 10/08/14 01:41:19 PM
#1189   Arrowhead down on hepatitis B data.. Way down.. RCH68 10/08/14 12:21:56 PM
#1188 RCH68 10/08/14 08:10:40 AM
#1187   GREAT NEWS from BENITEC georgejjl 10/08/14 12:15:09 AM
#1186   TT-­-034 HCV TRIAL UPDATE Sydney Australia, 8 October 2014: RNAi therapeutics compan Blane 10/07/14 09:35:08 PM
#1185   To be honest I think the tt-034 trial SmokeyNYY 10/07/14 09:02:27 PM
#1184   I wish they would give us news on RCH68 10/07/14 09:00:28 PM
#1183   Tanking over in aussie land again. I think SmokeyNYY 10/07/14 08:49:51 PM
#1182   Update RCH68 10/07/14 08:37:53 PM
#1181   Interesting from hotcopper georgejjl 10/06/14 11:40:14 PM
#1180   The peasants are getting restless. RCH68 10/06/14 07:15:11 AM
#1179   I do agree that it would be good georgejjl 10/06/14 01:48:17 AM
#1178   I do NOT agree in whole but I georgejjl 10/06/14 01:36:26 AM
#1177   Gene silencing for OPMD georgejjl 10/04/14 01:04:43 PM
#1176   ARC Linkage Grants georgejjl 10/04/14 12:18:53 PM
#1175   The Use of ddRNAi as a Permanent Gene georgejjl 10/04/14 12:05:57 PM
#1174   Biotech & Healthcare Investor Roadshow georgejjl 10/01/14 07:59:52 PM
#1173   Seems we will be stuck in the .90 SmokeyNYY 10/01/14 06:00:47 PM
#1172   Yeah, I agree with Panno. The decision Blane 10/01/14 11:12:55 AM
#1171   Sorry Blane i misquoted Buda, he said it RCH68 10/01/14 06:47:33 AM